nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ORM1—Vandetanib—thyroid cancer	0.236	0.288	CbGbCtD
Trazodone—HTR2B—Sorafenib—thyroid cancer	0.151	0.184	CbGbCtD
Trazodone—HTR2C—Sorafenib—thyroid cancer	0.0983	0.12	CbGbCtD
Trazodone—CYP3A7—Sorafenib—thyroid cancer	0.0641	0.0781	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0641	0.0781	CbGbCtD
Trazodone—CYP3A5—Sorafenib—thyroid cancer	0.0481	0.0586	CbGbCtD
Trazodone—ABCB1—Sorafenib—thyroid cancer	0.0313	0.0381	CbGbCtD
Trazodone—CYP3A4—Vandetanib—thyroid cancer	0.0311	0.0379	CbGbCtD
Trazodone—CYP2D6—Sorafenib—thyroid cancer	0.0295	0.0359	CbGbCtD
Trazodone—ABCB1—Doxorubicin—thyroid cancer	0.019	0.0231	CbGbCtD
Trazodone—CYP3A4—Sorafenib—thyroid cancer	0.0187	0.0229	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—thyroid cancer	0.0179	0.0218	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—thyroid cancer	0.0114	0.0139	CbGbCtD
Trazodone—Psoriasis—Doxorubicin—thyroid cancer	0.000905	0.00515	CcSEcCtD
Trazodone—Dry mouth—Vandetanib—thyroid cancer	0.000898	0.00511	CcSEcCtD
Trazodone—Oedema—Vandetanib—thyroid cancer	0.00088	0.00501	CcSEcCtD
Trazodone—Hypokinesia—Doxorubicin—thyroid cancer	0.000843	0.00479	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000802	0.00456	CcSEcCtD
Trazodone—Insomnia—Vandetanib—thyroid cancer	0.000796	0.00453	CcSEcCtD
Trazodone—Paraesthesia—Vandetanib—thyroid cancer	0.00079	0.00449	CcSEcCtD
Trazodone—Dyspnoea—Vandetanib—thyroid cancer	0.000784	0.00446	CcSEcCtD
Trazodone—Tinnitus—Sorafenib—thyroid cancer	0.000779	0.00443	CcSEcCtD
Trazodone—Flushing—Sorafenib—thyroid cancer	0.000775	0.00441	CcSEcCtD
Trazodone—Decreased appetite—Vandetanib—thyroid cancer	0.000765	0.00435	CcSEcCtD
Trazodone—Fatigue—Vandetanib—thyroid cancer	0.000759	0.00432	CcSEcCtD
Trazodone—Constipation—Vandetanib—thyroid cancer	0.000752	0.00428	CcSEcCtD
Trazodone—Pain—Vandetanib—thyroid cancer	0.000752	0.00428	CcSEcCtD
Trazodone—Arrhythmia—Sorafenib—thyroid cancer	0.000746	0.00425	CcSEcCtD
Trazodone—Alopecia—Sorafenib—thyroid cancer	0.000738	0.0042	CcSEcCtD
Trazodone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000719	0.00409	CcSEcCtD
Trazodone—Dysgeusia—Sorafenib—thyroid cancer	0.000712	0.00405	CcSEcCtD
Trazodone—Jaundice cholestatic—Epirubicin—thyroid cancer	0.0007	0.00398	CcSEcCtD
Trazodone—Vasodilation procedure—Epirubicin—thyroid cancer	0.0007	0.00398	CcSEcCtD
Trazodone—Vasodilation—Epirubicin—thyroid cancer	0.0007	0.00398	CcSEcCtD
Trazodone—Abdominal pain—Vandetanib—thyroid cancer	0.000695	0.00396	CcSEcCtD
Trazodone—Body temperature increased—Vandetanib—thyroid cancer	0.000695	0.00396	CcSEcCtD
Trazodone—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.000681	0.00387	CcSEcCtD
Trazodone—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.000676	0.00385	CcSEcCtD
Trazodone—Anaemia—Sorafenib—thyroid cancer	0.000672	0.00382	CcSEcCtD
Trazodone—Dyskinesia—Epirubicin—thyroid cancer	0.000654	0.00372	CcSEcCtD
Trazodone—Syncope—Sorafenib—thyroid cancer	0.000652	0.00371	CcSEcCtD
Trazodone—Dysarthria—Epirubicin—thyroid cancer	0.00065	0.0037	CcSEcCtD
Trazodone—Vasodilation—Doxorubicin—thyroid cancer	0.000647	0.00368	CcSEcCtD
Trazodone—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000647	0.00368	CcSEcCtD
Trazodone—Vasodilation procedure—Doxorubicin—thyroid cancer	0.000647	0.00368	CcSEcCtD
Trazodone—Loss of consciousness—Sorafenib—thyroid cancer	0.000639	0.00364	CcSEcCtD
Trazodone—Atrioventricular block—Epirubicin—thyroid cancer	0.000634	0.00361	CcSEcCtD
Trazodone—Asthenia—Vandetanib—thyroid cancer	0.000631	0.00359	CcSEcCtD
Trazodone—Gait disturbance—Epirubicin—thyroid cancer	0.00063	0.00358	CcSEcCtD
Trazodone—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00063	0.00358	CcSEcCtD
Trazodone—Hypertension—Sorafenib—thyroid cancer	0.000628	0.00357	CcSEcCtD
Trazodone—Coordination abnormal—Epirubicin—thyroid cancer	0.000626	0.00356	CcSEcCtD
Trazodone—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.000626	0.00356	CcSEcCtD
Trazodone—Pruritus—Vandetanib—thyroid cancer	0.000622	0.00354	CcSEcCtD
Trazodone—Arthralgia—Sorafenib—thyroid cancer	0.000619	0.00352	CcSEcCtD
Trazodone—Myalgia—Sorafenib—thyroid cancer	0.000619	0.00352	CcSEcCtD
Trazodone—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000615	0.0035	CcSEcCtD
Trazodone—Abnormal dreams—Epirubicin—thyroid cancer	0.000608	0.00346	CcSEcCtD
Trazodone—Dry mouth—Sorafenib—thyroid cancer	0.000605	0.00344	CcSEcCtD
Trazodone—Dyskinesia—Doxorubicin—thyroid cancer	0.000605	0.00344	CcSEcCtD
Trazodone—Diarrhoea—Vandetanib—thyroid cancer	0.000602	0.00342	CcSEcCtD
Trazodone—Dysarthria—Doxorubicin—thyroid cancer	0.000601	0.00342	CcSEcCtD
Trazodone—Salivary hypersecretion—Epirubicin—thyroid cancer	0.000597	0.0034	CcSEcCtD
Trazodone—Atrioventricular block—Doxorubicin—thyroid cancer	0.000586	0.00334	CcSEcCtD
Trazodone—Shock—Sorafenib—thyroid cancer	0.000584	0.00332	CcSEcCtD
Trazodone—Gait disturbance—Doxorubicin—thyroid cancer	0.000583	0.00332	CcSEcCtD
Trazodone—Dizziness—Vandetanib—thyroid cancer	0.000582	0.00331	CcSEcCtD
Trazodone—Coordination abnormal—Doxorubicin—thyroid cancer	0.000579	0.0033	CcSEcCtD
Trazodone—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000569	0.00324	CcSEcCtD
Trazodone—Dry eye—Epirubicin—thyroid cancer	0.000568	0.00323	CcSEcCtD
Trazodone—Anorexia—Sorafenib—thyroid cancer	0.000566	0.00322	CcSEcCtD
Trazodone—Abnormal dreams—Doxorubicin—thyroid cancer	0.000562	0.0032	CcSEcCtD
Trazodone—Vomiting—Vandetanib—thyroid cancer	0.000559	0.00318	CcSEcCtD
Trazodone—Bladder pain—Epirubicin—thyroid cancer	0.000556	0.00316	CcSEcCtD
Trazodone—Rash—Vandetanib—thyroid cancer	0.000555	0.00316	CcSEcCtD
Trazodone—Dermatitis—Vandetanib—thyroid cancer	0.000554	0.00315	CcSEcCtD
Trazodone—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000552	0.00314	CcSEcCtD
Trazodone—Headache—Vandetanib—thyroid cancer	0.000551	0.00314	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000541	0.00308	CcSEcCtD
Trazodone—Mental disability—Epirubicin—thyroid cancer	0.000533	0.00304	CcSEcCtD
Trazodone—Dyspnoea—Sorafenib—thyroid cancer	0.000529	0.00301	CcSEcCtD
Trazodone—Dry eye—Doxorubicin—thyroid cancer	0.000525	0.00299	CcSEcCtD
Trazodone—Nausea—Vandetanib—thyroid cancer	0.000523	0.00297	CcSEcCtD
Trazodone—Decreased appetite—Sorafenib—thyroid cancer	0.000516	0.00294	CcSEcCtD
Trazodone—Bladder pain—Doxorubicin—thyroid cancer	0.000514	0.00293	CcSEcCtD
Trazodone—Fatigue—Sorafenib—thyroid cancer	0.000512	0.00291	CcSEcCtD
Trazodone—Photosensitivity—Epirubicin—thyroid cancer	0.000508	0.00289	CcSEcCtD
Trazodone—Pain—Sorafenib—thyroid cancer	0.000508	0.00289	CcSEcCtD
Trazodone—Constipation—Sorafenib—thyroid cancer	0.000508	0.00289	CcSEcCtD
Trazodone—Eye pain—Epirubicin—thyroid cancer	0.000494	0.00281	CcSEcCtD
Trazodone—Mental disability—Doxorubicin—thyroid cancer	0.000494	0.00281	CcSEcCtD
Trazodone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000492	0.0028	CcSEcCtD
Trazodone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000485	0.00276	CcSEcCtD
Trazodone—Increased appetite—Epirubicin—thyroid cancer	0.000475	0.0027	CcSEcCtD
Trazodone—Urticaria—Sorafenib—thyroid cancer	0.000471	0.00268	CcSEcCtD
Trazodone—Photosensitivity—Doxorubicin—thyroid cancer	0.00047	0.00268	CcSEcCtD
Trazodone—Abdominal pain—Sorafenib—thyroid cancer	0.000469	0.00267	CcSEcCtD
Trazodone—Body temperature increased—Sorafenib—thyroid cancer	0.000469	0.00267	CcSEcCtD
Trazodone—Eye pain—Doxorubicin—thyroid cancer	0.000457	0.0026	CcSEcCtD
Trazodone—Lethargy—Epirubicin—thyroid cancer	0.000455	0.00259	CcSEcCtD
Trazodone—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000455	0.00259	CcSEcCtD
Trazodone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000455	0.00259	CcSEcCtD
Trazodone—Hyponatraemia—Epirubicin—thyroid cancer	0.000448	0.00255	CcSEcCtD
Trazodone—Diplopia—Epirubicin—thyroid cancer	0.000446	0.00254	CcSEcCtD
Trazodone—Increased appetite—Doxorubicin—thyroid cancer	0.000439	0.0025	CcSEcCtD
Trazodone—Migraine—Epirubicin—thyroid cancer	0.000439	0.0025	CcSEcCtD
Trazodone—Hypersensitivity—Sorafenib—thyroid cancer	0.000437	0.00249	CcSEcCtD
Trazodone—Asthenia—Sorafenib—thyroid cancer	0.000426	0.00242	CcSEcCtD
Trazodone—Cardiac arrest—Epirubicin—thyroid cancer	0.000424	0.00241	CcSEcCtD
Trazodone—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000421	0.0024	CcSEcCtD
Trazodone—Lethargy—Doxorubicin—thyroid cancer	0.000421	0.0024	CcSEcCtD
Trazodone—Pruritus—Sorafenib—thyroid cancer	0.00042	0.00239	CcSEcCtD
Trazodone—Ataxia—Epirubicin—thyroid cancer	0.00042	0.00239	CcSEcCtD
Trazodone—Hyponatraemia—Doxorubicin—thyroid cancer	0.000415	0.00236	CcSEcCtD
Trazodone—Diplopia—Doxorubicin—thyroid cancer	0.000413	0.00235	CcSEcCtD
Trazodone—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000408	0.00232	CcSEcCtD
Trazodone—Migraine—Doxorubicin—thyroid cancer	0.000406	0.00231	CcSEcCtD
Trazodone—Diarrhoea—Sorafenib—thyroid cancer	0.000406	0.00231	CcSEcCtD
Trazodone—Cardiac arrest—Doxorubicin—thyroid cancer	0.000393	0.00223	CcSEcCtD
Trazodone—Dizziness—Sorafenib—thyroid cancer	0.000392	0.00223	CcSEcCtD
Trazodone—Ataxia—Doxorubicin—thyroid cancer	0.000388	0.00221	CcSEcCtD
Trazodone—Vomiting—Sorafenib—thyroid cancer	0.000377	0.00215	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000377	0.00215	CcSEcCtD
Trazodone—Rash—Sorafenib—thyroid cancer	0.000374	0.00213	CcSEcCtD
Trazodone—Dermatitis—Sorafenib—thyroid cancer	0.000374	0.00213	CcSEcCtD
Trazodone—Headache—Sorafenib—thyroid cancer	0.000372	0.00212	CcSEcCtD
Trazodone—Pollakiuria—Epirubicin—thyroid cancer	0.000356	0.00203	CcSEcCtD
Trazodone—Nausea—Sorafenib—thyroid cancer	0.000353	0.00201	CcSEcCtD
Trazodone—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000352	0.002	CcSEcCtD
Trazodone—Weight increased—Epirubicin—thyroid cancer	0.000351	0.002	CcSEcCtD
Trazodone—Weight decreased—Epirubicin—thyroid cancer	0.000349	0.00199	CcSEcCtD
Trazodone—Drowsiness—Epirubicin—thyroid cancer	0.000344	0.00196	CcSEcCtD
Trazodone—Jaundice—Epirubicin—thyroid cancer	0.000335	0.00191	CcSEcCtD
Trazodone—Sweating—Epirubicin—thyroid cancer	0.00033	0.00188	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—thyroid cancer	0.00033	0.00188	CcSEcCtD
Trazodone—Haematuria—Epirubicin—thyroid cancer	0.000328	0.00187	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000326	0.00185	CcSEcCtD
Trazodone—Weight increased—Doxorubicin—thyroid cancer	0.000325	0.00185	CcSEcCtD
Trazodone—Weight decreased—Doxorubicin—thyroid cancer	0.000323	0.00184	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—thyroid cancer	0.000318	0.00181	CcSEcCtD
Trazodone—Bradycardia—Epirubicin—thyroid cancer	0.000314	0.00179	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—thyroid cancer	0.00031	0.00176	CcSEcCtD
Trazodone—Hypoaesthesia—Epirubicin—thyroid cancer	0.000307	0.00175	CcSEcCtD
Trazodone—Sweating—Doxorubicin—thyroid cancer	0.000305	0.00174	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—thyroid cancer	0.000303	0.00173	CcSEcCtD
Trazodone—Visual impairment—Epirubicin—thyroid cancer	0.000298	0.00169	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—thyroid cancer	0.000291	0.00165	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—thyroid cancer	0.000288	0.00164	CcSEcCtD
Trazodone—Flushing—Epirubicin—thyroid cancer	0.000287	0.00163	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000284	0.00162	CcSEcCtD
Trazodone—Chills—Epirubicin—thyroid cancer	0.000277	0.00158	CcSEcCtD
Trazodone—Arrhythmia—Epirubicin—thyroid cancer	0.000276	0.00157	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—thyroid cancer	0.000275	0.00157	CcSEcCtD
Trazodone—Alopecia—Epirubicin—thyroid cancer	0.000273	0.00155	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—thyroid cancer	0.000266	0.00152	CcSEcCtD
Trazodone—Flushing—Doxorubicin—thyroid cancer	0.000265	0.00151	CcSEcCtD
Trazodone—Flatulence—Epirubicin—thyroid cancer	0.000265	0.00151	CcSEcCtD
Trazodone—Tension—Epirubicin—thyroid cancer	0.000264	0.0015	CcSEcCtD
Trazodone—Dysgeusia—Epirubicin—thyroid cancer	0.000263	0.0015	CcSEcCtD
Trazodone—Nervousness—Epirubicin—thyroid cancer	0.000261	0.00148	CcSEcCtD
Trazodone—Back pain—Epirubicin—thyroid cancer	0.00026	0.00148	CcSEcCtD
Trazodone—Chills—Doxorubicin—thyroid cancer	0.000256	0.00146	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—thyroid cancer	0.000255	0.00145	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—thyroid cancer	0.000253	0.00144	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—thyroid cancer	0.000252	0.00144	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000249	0.00142	CcSEcCtD
Trazodone—Anaemia—Epirubicin—thyroid cancer	0.000248	0.00141	CcSEcCtD
Trazodone—Agitation—Epirubicin—thyroid cancer	0.000247	0.00141	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—thyroid cancer	0.000245	0.00139	CcSEcCtD
Trazodone—Tension—Doxorubicin—thyroid cancer	0.000244	0.00139	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—thyroid cancer	0.000244	0.00139	CcSEcCtD
Trazodone—Malaise—Epirubicin—thyroid cancer	0.000242	0.00138	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—thyroid cancer	0.000242	0.00137	CcSEcCtD
Trazodone—Vertigo—Epirubicin—thyroid cancer	0.000241	0.00137	CcSEcCtD
Trazodone—Syncope—Epirubicin—thyroid cancer	0.000241	0.00137	CcSEcCtD
Trazodone—Back pain—Doxorubicin—thyroid cancer	0.000241	0.00137	CcSEcCtD
Trazodone—Palpitations—Epirubicin—thyroid cancer	0.000237	0.00135	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—thyroid cancer	0.000236	0.00134	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—thyroid cancer	0.000234	0.00133	CcSEcCtD
Trazodone—Hypertension—Epirubicin—thyroid cancer	0.000232	0.00132	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000231	0.00131	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—thyroid cancer	0.00023	0.00131	CcSEcCtD
Trazodone—Chest pain—Epirubicin—thyroid cancer	0.000229	0.0013	CcSEcCtD
Trazodone—Myalgia—Epirubicin—thyroid cancer	0.000229	0.0013	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—thyroid cancer	0.000229	0.0013	CcSEcCtD
Trazodone—Agitation—Doxorubicin—thyroid cancer	0.000229	0.0013	CcSEcCtD
Trazodone—Anxiety—Epirubicin—thyroid cancer	0.000228	0.0013	CcSEcCtD
Trazodone—Discomfort—Epirubicin—thyroid cancer	0.000226	0.00129	CcSEcCtD
Trazodone—Malaise—Doxorubicin—thyroid cancer	0.000224	0.00128	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—thyroid cancer	0.000224	0.00127	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—thyroid cancer	0.000223	0.00127	CcSEcCtD
Trazodone—Syncope—Doxorubicin—thyroid cancer	0.000223	0.00127	CcSEcCtD
Trazodone—Confusional state—Epirubicin—thyroid cancer	0.000221	0.00126	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—thyroid cancer	0.00022	0.00125	CcSEcCtD
Trazodone—Oedema—Epirubicin—thyroid cancer	0.000219	0.00125	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000219	0.00124	CcSEcCtD
Trazodone—Shock—Epirubicin—thyroid cancer	0.000216	0.00123	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—thyroid cancer	0.000215	0.00122	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—thyroid cancer	0.000214	0.00122	CcSEcCtD
Trazodone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000212	0.00121	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—thyroid cancer	0.000212	0.0012	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—thyroid cancer	0.000212	0.0012	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—thyroid cancer	0.000212	0.0012	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—thyroid cancer	0.000211	0.0012	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—thyroid cancer	0.000209	0.00119	CcSEcCtD
Trazodone—Anorexia—Epirubicin—thyroid cancer	0.000209	0.00119	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—thyroid cancer	0.000207	0.00118	CcSEcCtD
Trazodone—Hypotension—Epirubicin—thyroid cancer	0.000205	0.00117	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—thyroid cancer	0.000205	0.00116	CcSEcCtD
Trazodone—Oedema—Doxorubicin—thyroid cancer	0.000203	0.00115	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.0002	0.00114	CcSEcCtD
Trazodone—Shock—Doxorubicin—thyroid cancer	0.0002	0.00114	CcSEcCtD
Trazodone—Insomnia—Epirubicin—thyroid cancer	0.000198	0.00113	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—thyroid cancer	0.000198	0.00113	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—thyroid cancer	0.000197	0.00112	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000196	0.00112	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—thyroid cancer	0.000196	0.00111	CcSEcCtD
Trazodone—Somnolence—Epirubicin—thyroid cancer	0.000195	0.00111	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—thyroid cancer	0.000193	0.0011	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—thyroid cancer	0.000191	0.00108	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—thyroid cancer	0.00019	0.00108	CcSEcCtD
Trazodone—Fatigue—Epirubicin—thyroid cancer	0.000189	0.00108	CcSEcCtD
Trazodone—Constipation—Epirubicin—thyroid cancer	0.000188	0.00107	CcSEcCtD
Trazodone—Pain—Epirubicin—thyroid cancer	0.000188	0.00107	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000185	0.00105	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—thyroid cancer	0.000184	0.00104	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—thyroid cancer	0.000182	0.00104	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—thyroid cancer	0.000181	0.00103	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—thyroid cancer	0.000181	0.00103	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—thyroid cancer	0.00018	0.00103	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000179	0.00102	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—thyroid cancer	0.000176	0.001	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—thyroid cancer	0.000175	0.000995	CcSEcCtD
Trazodone—Urticaria—Epirubicin—thyroid cancer	0.000174	0.000991	CcSEcCtD
Trazodone—Constipation—Doxorubicin—thyroid cancer	0.000174	0.000987	CcSEcCtD
Trazodone—Pain—Doxorubicin—thyroid cancer	0.000174	0.000987	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—thyroid cancer	0.000173	0.000986	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—thyroid cancer	0.000173	0.000986	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000167	0.000951	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000166	0.000944	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—thyroid cancer	0.000162	0.000919	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—thyroid cancer	0.000161	0.000917	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—thyroid cancer	0.00016	0.000913	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—thyroid cancer	0.00016	0.000913	CcSEcCtD
Trazodone—Asthenia—Epirubicin—thyroid cancer	0.000157	0.000895	CcSEcCtD
Trazodone—Pruritus—Epirubicin—thyroid cancer	0.000155	0.000883	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—thyroid cancer	0.00015	0.000854	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—thyroid cancer	0.00015	0.000851	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—thyroid cancer	0.000146	0.000828	CcSEcCtD
Trazodone—Dizziness—Epirubicin—thyroid cancer	0.000145	0.000825	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—thyroid cancer	0.000144	0.000817	CcSEcCtD
Trazodone—Vomiting—Epirubicin—thyroid cancer	0.000139	0.000793	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—thyroid cancer	0.000139	0.00079	CcSEcCtD
Trazodone—Rash—Epirubicin—thyroid cancer	0.000138	0.000787	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—thyroid cancer	0.000138	0.000786	CcSEcCtD
Trazodone—Headache—Epirubicin—thyroid cancer	0.000137	0.000782	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—thyroid cancer	0.000134	0.000763	CcSEcCtD
Trazodone—Nausea—Epirubicin—thyroid cancer	0.00013	0.000741	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—thyroid cancer	0.000129	0.000734	CcSEcCtD
Trazodone—Rash—Doxorubicin—thyroid cancer	0.000128	0.000728	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—thyroid cancer	0.000128	0.000727	CcSEcCtD
Trazodone—Headache—Doxorubicin—thyroid cancer	0.000127	0.000723	CcSEcCtD
Trazodone—Nausea—Doxorubicin—thyroid cancer	0.000121	0.000686	CcSEcCtD
Trazodone—ADRA1A—Signaling Pathways—TCF7L1—thyroid cancer	4.36e-06	0.00112	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CDK1—thyroid cancer	4.32e-06	0.00111	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CDK1—thyroid cancer	4.3e-06	0.0011	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—SST—thyroid cancer	4.3e-06	0.0011	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—SST—thyroid cancer	4.29e-06	0.0011	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—SST—thyroid cancer	4.28e-06	0.0011	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—HPGD—thyroid cancer	4.27e-06	0.00109	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PTCH1—thyroid cancer	4.27e-06	0.00109	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—SST—thyroid cancer	4.2e-06	0.00108	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CALCA—thyroid cancer	4.14e-06	0.00106	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CALCA—thyroid cancer	4.13e-06	0.00106	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CALCA—thyroid cancer	4.12e-06	0.00106	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.12e-06	0.00105	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.08e-06	0.00105	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TCF7L1—thyroid cancer	4.05e-06	0.00104	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CALCA—thyroid cancer	4.04e-06	0.00104	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HPGD—thyroid cancer	4.02e-06	0.00103	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.99e-06	0.00102	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.98e-06	0.00102	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTCH1—thyroid cancer	3.95e-06	0.00101	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.92e-06	0.001	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.9e-06	0.001	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.9e-06	0.001	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—SST—thyroid cancer	3.9e-06	0.001	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TSHR—thyroid cancer	3.77e-06	0.000966	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	3.76e-06	0.000962	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TSHR—thyroid cancer	3.75e-06	0.000961	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CDK1—thyroid cancer	3.74e-06	0.000957	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CDK1—thyroid cancer	3.73e-06	0.000955	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.72e-06	0.000953	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PRKAR1A—thyroid cancer	3.71e-06	0.000951	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PRKAR1A—thyroid cancer	3.69e-06	0.000946	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CDK1—thyroid cancer	3.66e-06	0.000937	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SST—thyroid cancer	3.62e-06	0.000927	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.59e-06	0.00092	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MEN1—thyroid cancer	3.54e-06	0.000908	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—TPR—thyroid cancer	3.54e-06	0.000908	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MEN1—thyroid cancer	3.53e-06	0.000904	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	3.49e-06	0.000893	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CALCA—thyroid cancer	3.48e-06	0.000892	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.47e-06	0.000889	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	3.4e-06	0.000871	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.39e-06	0.000868	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.38e-06	0.000866	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.36e-06	0.000862	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.32e-06	0.00085	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.29e-06	0.000843	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CHST14—thyroid cancer	3.26e-06	0.000836	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TSHR—thyroid cancer	3.26e-06	0.000835	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TSHR—thyroid cancer	3.25e-06	0.000833	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—TPR—thyroid cancer	3.25e-06	0.000832	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTCH1—thyroid cancer	3.21e-06	0.000822	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PRKAR1A—thyroid cancer	3.2e-06	0.000821	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PRKAR1A—thyroid cancer	3.2e-06	0.000819	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.2e-06	0.000819	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TSHR—thyroid cancer	3.19e-06	0.000817	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTCH1—thyroid cancer	3.19e-06	0.000817	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CDK1—thyroid cancer	3.15e-06	0.000807	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PRKAR1A—thyroid cancer	3.14e-06	0.000804	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MEN1—thyroid cancer	3.06e-06	0.000785	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MEN1—thyroid cancer	3.06e-06	0.000783	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MEN1—thyroid cancer	3e-06	0.000768	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	2.96e-06	0.000759	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SST—thyroid cancer	2.93e-06	0.000751	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SST—thyroid cancer	2.92e-06	0.000748	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	2.92e-06	0.000747	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—RXRA—thyroid cancer	2.83e-06	0.000724	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CALCA—thyroid cancer	2.82e-06	0.000723	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CALCA—thyroid cancer	2.81e-06	0.00072	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	2.79e-06	0.000714	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTCH1—thyroid cancer	2.77e-06	0.00071	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTCH1—thyroid cancer	2.76e-06	0.000708	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.76e-06	0.000706	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	2.71e-06	0.000695	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.66e-06	0.000682	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—SLC5A5—thyroid cancer	2.65e-06	0.00068	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HPGD—thyroid cancer	2.63e-06	0.000674	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CDK1—thyroid cancer	2.55e-06	0.000655	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDK1—thyroid cancer	2.54e-06	0.000651	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SST—thyroid cancer	2.53e-06	0.000649	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NRG1—thyroid cancer	2.53e-06	0.000648	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SST—thyroid cancer	2.53e-06	0.000648	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	2.52e-06	0.000646	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SST—thyroid cancer	2.48e-06	0.000636	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TPR—thyroid cancer	2.45e-06	0.000628	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.45e-06	0.000628	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CALCA—thyroid cancer	2.44e-06	0.000625	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CALCA—thyroid cancer	2.43e-06	0.000623	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.43e-06	0.000623	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.41e-06	0.000618	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	2.39e-06	0.000612	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TPR—thyroid cancer	2.31e-06	0.000592	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SST—thyroid cancer	2.3e-06	0.000591	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.27e-06	0.000582	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TERT—thyroid cancer	2.27e-06	0.000582	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—RXRA—thyroid cancer	2.23e-06	0.000571	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	2.22e-06	0.000568	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDK1—thyroid cancer	2.21e-06	0.000566	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDK1—thyroid cancer	2.2e-06	0.000564	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HIF1A—thyroid cancer	2.17e-06	0.000556	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	2.16e-06	0.000554	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—NRAS—thyroid cancer	2.12e-06	0.000544	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.07e-06	0.00053	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NRG1—thyroid cancer	2.05e-06	0.000526	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—RXRA—thyroid cancer	2.04e-06	0.000523	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NRG1—thyroid cancer	2.04e-06	0.000523	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	2.01e-06	0.000515	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—NRAS—thyroid cancer	1.91e-06	0.00049	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TERT—thyroid cancer	1.84e-06	0.000472	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.83e-06	0.00047	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TERT—thyroid cancer	1.83e-06	0.000469	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—KRAS—thyroid cancer	1.83e-06	0.000469	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—BRAF—thyroid cancer	1.8e-06	0.000461	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PPARG—thyroid cancer	1.78e-06	0.000457	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NRG1—thyroid cancer	1.77e-06	0.000454	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NRG1—thyroid cancer	1.77e-06	0.000453	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	1.76e-06	0.000451	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	1.75e-06	0.000449	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	1.73e-06	0.000445	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.73e-06	0.000443	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	1.65e-06	0.000422	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—thyroid cancer	1.63e-06	0.000416	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.61e-06	0.000413	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.59e-06	0.000408	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TERT—thyroid cancer	1.59e-06	0.000407	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TERT—thyroid cancer	1.56e-06	0.000399	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.55e-06	0.000398	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.55e-06	0.000398	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.54e-06	0.000395	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—RXRA—thyroid cancer	1.54e-06	0.000395	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.52e-06	0.00039	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.52e-06	0.000389	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TPR—thyroid cancer	1.51e-06	0.000387	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.49e-06	0.000382	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.49e-06	0.000381	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.46e-06	0.000374	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—RXRA—thyroid cancer	1.45e-06	0.000372	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.45e-06	0.000372	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.45e-06	0.000371	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PPARG—thyroid cancer	1.41e-06	0.000361	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.4e-06	0.00036	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.4e-06	0.000359	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.38e-06	0.000355	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.37e-06	0.000352	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.36e-06	0.000349	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.34e-06	0.000343	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.34e-06	0.000343	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.34e-06	0.000342	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.33e-06	0.00034	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.31e-06	0.000336	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.31e-06	0.000336	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PPARG—thyroid cancer	1.29e-06	0.00033	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.27e-06	0.000325	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.26e-06	0.000323	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.26e-06	0.000322	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.24e-06	0.000317	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.23e-06	0.000316	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTEN—thyroid cancer	1.22e-06	0.000314	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.22e-06	0.000312	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.15e-06	0.000296	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.15e-06	0.000295	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.15e-06	0.000294	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.13e-06	0.000291	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.13e-06	0.00029	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.13e-06	0.00029	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.13e-06	0.000289	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.13e-06	0.000289	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.11e-06	0.000284	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.1e-06	0.000283	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.1e-06	0.000281	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.06e-06	0.000273	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.06e-06	0.000271	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.05e-06	0.000269	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.03e-06	0.000263	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.02e-06	0.000262	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.01e-06	0.00026	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1e-06	0.000257	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	9.97e-07	0.000255	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	9.8e-07	0.000251	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HRAS—thyroid cancer	9.78e-07	0.000251	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARG—thyroid cancer	9.73e-07	0.000249	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KRAS—thyroid cancer	9.73e-07	0.000249	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTEN—thyroid cancer	9.66e-07	0.000247	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	9.6e-07	0.000246	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	9.53e-07	0.000244	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	9.51e-07	0.000244	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—RXRA—thyroid cancer	9.5e-07	0.000243	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	9.33e-07	0.000239	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCND1—thyroid cancer	9.19e-07	0.000236	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCND1—thyroid cancer	9.17e-07	0.000235	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARG—thyroid cancer	9.17e-07	0.000235	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NRAS—thyroid cancer	9.16e-07	0.000235	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NRAS—thyroid cancer	9.12e-07	0.000234	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	9e-07	0.000231	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	8.92e-07	0.000229	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTEN—thyroid cancer	8.87e-07	0.000227	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTEN—thyroid cancer	8.86e-07	0.000227	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTEN—thyroid cancer	8.85e-07	0.000227	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	8.69e-07	0.000223	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	8.67e-07	0.000222	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	8.66e-07	0.000222	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—thyroid cancer	8.64e-07	0.000222	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—thyroid cancer	8.64e-07	0.000221	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	8.48e-07	0.000217	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	8.36e-07	0.000214	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HRAS—thyroid cancer	8.27e-07	0.000212	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	8.07e-07	0.000207	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NRAS—thyroid cancer	7.92e-07	0.000203	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NRAS—thyroid cancer	7.9e-07	0.000202	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KRAS—thyroid cancer	7.89e-07	0.000202	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	7.88e-07	0.000202	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KRAS—thyroid cancer	7.85e-07	0.000201	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	7.75e-07	0.000199	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—thyroid cancer	7.66e-07	0.000196	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—thyroid cancer	7.3e-07	0.000187	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.21e-07	0.000185	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	7.2e-07	0.000185	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—thyroid cancer	7.05e-07	0.000181	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—thyroid cancer	7.01e-07	0.00018	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—thyroid cancer	6.97e-07	0.000179	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KRAS—thyroid cancer	6.81e-07	0.000175	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KRAS—thyroid cancer	6.8e-07	0.000174	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HRAS—thyroid cancer	6.7e-07	0.000172	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTEN—thyroid cancer	6.68e-07	0.000171	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	6.67e-07	0.000171	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HRAS—thyroid cancer	6.67e-07	0.000171	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTEN—thyroid cancer	6.29e-07	0.000161	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	6.2e-07	0.000159	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—thyroid cancer	6.06e-07	0.000155	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—thyroid cancer	6.04e-07	0.000155	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARG—thyroid cancer	6e-07	0.000154	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—thyroid cancer	5.93e-07	0.000152	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—thyroid cancer	5.92e-07	0.000152	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—thyroid cancer	5.89e-07	0.000151	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HRAS—thyroid cancer	5.79e-07	0.000148	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HRAS—thyroid cancer	5.78e-07	0.000148	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	5.67e-07	0.000145	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—thyroid cancer	5.56e-07	0.000143	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—thyroid cancer	5.51e-07	0.000141	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	5.27e-07	0.000135	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—thyroid cancer	5.11e-07	0.000131	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—thyroid cancer	5.1e-07	0.000131	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—thyroid cancer	5.1e-07	0.000131	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	5.01e-07	0.000128	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.72e-07	0.000121	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	4.65e-07	0.000119	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTEN—thyroid cancer	4.11e-07	0.000105	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—thyroid cancer	3.85e-07	9.86e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—thyroid cancer	3.63e-07	9.29e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—thyroid cancer	2.37e-07	6.07e-05	CbGpPWpGaD
